Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
No Thumbnail Available
Date
2002
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Insulin plays a major role in polycystic ovary syndrome (PCOS). Insulin resistance and resultant hyperinsulinemia stimulate both the ovary and adrenal to produce androgens. Oral antidiabetic agents have been used to alleviate the symptoms and to induce ovulation in women with PCOS. This review focuses on the relation between insulin and PCOS and discusses the use of oral antidiabetic agents.
Description
Keywords
Administration, Oral , Chromans , Female , Humans , Hypoglycemic Agents , Insulin , Metformin , Ovulation , Polycystic Ovary Syndrome , Thiazoles , Thiazolidinediones , 2,4 thiazolidinedione derivative , antidiabetic agent , chroman derivative , insulin , metformin , thiazole derivative , troglitazone , drug effect , female , human , oral drug administration , ovary polycystic disease , ovulation , pathophysiology , review